New Delhi [India], March 9 (ANI): Hyderabad-based pharmaceutical company Biological E has applied for Emergency Use Authorisation (EUA) for its COVID-19 vaccine Corbevax for the 5-12 year age group, official sources said on Wednesday.
New Delhi [India], February 22 (ANI): The Central Drugs Laboratory (CDL), Kasauli, has cleared almost 6.5 crore doses of Biological E's COVID-19 vaccine Corbevax based on safety, quality and efficacy parameters, sources said on Tuesday.
New Delhi [India], February 21 (ANI): Hyderabad-based pharmaceutical company Biological E on Monday received emergency use authorisation from Drugs Controller General of India (DCGI) for its COVID-19 vaccine Corbevax for the 12 to 18 age group.
New Delhi [India], February 15 (ANI): The Drugs Controller General of India (DCGI)'s Subject Expert Committee (SEC) has recommended Emergency Use Authorization to Hyderabad-based pharmaceutical company Biological E's COVID-19 vaccine, Corbevax, for the age group 12 to 18 years subject to
New Delhi [India], February 5 (ANI): The Central government has placed an order with Hyderabad based Pharmaceutical company Biological E for five crore doses of 'Corbevax' COVID-19 vaccine with each dose costing Rs 145, said sources.
New Delhi [India], September 2 (ANI): Hyderabad-based pharmaceutical company, Biological E, is expected to launch its vaccine against coronavirus in October this year, according to Dr V K Paul, Member (Health), NITI Aayog.
New Delhi [India], July 26 (ANI): The Hyderabad-based pharmaceutical company Biological E is expected to launch its COVID-19 vaccine Corbevax by September end in India, said sources on Monday.